These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8303307)

  • 1. Antigen processing: a critical factor in rational vaccine design.
    Yewdell JW; Bennink JR
    Semin Hematol; 1993 Oct; 30(4 Suppl 4):26-32; discussion 33-4. PubMed ID: 8303307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular basis for detection of infectious agents].
    Siegrist CA
    Schweiz Med Wochenschr; 1996 Feb; 126(7):246-54. PubMed ID: 8720322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MHC class I antigen presentation--recently trimmed and well presented.
    Flutter B; Gao B
    Cell Mol Immunol; 2004 Feb; 1(1):22-30. PubMed ID: 16212917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HLA system, antigen processing and presentation.
    Krensky AM
    Kidney Int Suppl; 1997 Mar; 58():S2-7. PubMed ID: 9067934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-presentation: underlying mechanisms and role in immune surveillance.
    Rock KL; Shen L
    Immunol Rev; 2005 Oct; 207():166-83. PubMed ID: 16181335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural implications for the design of molecular vaccines.
    Apostolopoulos V; Yu M; McKenzie IF; Wilson IA
    Curr Opin Mol Ther; 2000 Feb; 2(1):29-36. PubMed ID: 11249650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Processing of bacterial antigens for presentation to class I and II MHC-restricted T lymphocytes.
    Harding CV; Song R; Griffin J; France J; Wick MJ; Pfeifer JD; Geuze HJ
    Infect Agents Dis; 1995 Mar; 4(1):1-12. PubMed ID: 7728352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MHC: function and implication on vaccine development.
    Eckels DD
    Vox Sang; 2000; 78 Suppl 2():265-7. PubMed ID: 10938966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat shock proteins implicated in antigen processing and presentation.
    De Nagel DC; Pierce SK
    Semin Immunol; 1991 Jan; 3(1):65-71. PubMed ID: 1716503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating peptide repertoires within the context of thymocyte development.
    Barton GM; Rudensky AY
    Semin Immunol; 1999 Dec; 11(6):417-22. PubMed ID: 10625595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
    Dobaño C; Rogers WO; Gowda K; Doolan DL
    Immunol Lett; 2007 Aug; 111(2):92-102. PubMed ID: 17604849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-presenting cells and the selection of immunodominant epitopes.
    Blum JS; Ma C; Kovats S
    Crit Rev Immunol; 1997; 17(5-6):411-7. PubMed ID: 9419428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The intracellular assembly of antigenic-peptide-class II complexes.
    Pierce SK; Green JM; Faassen AE; Xu X; Song W; Cho H; Schafer P; Psaradellis T; Wagle N; Kim J
    Biomed Pept Proteins Nucleic Acids; 1995; 1(3):149-56. PubMed ID: 9346846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of MHC-presented peptides: applications in autoimmunity and vaccine development.
    Chicz RM; Urban RG
    Immunol Today; 1994 Apr; 15(4):155-60. PubMed ID: 7515244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between peptides and major histocompatibility complex molecules during antigen processing and presentation.
    Forquet F; Danilczyk U; Lang Y; Delovitch TL
    Chem Immunol; 1993; 57():63-87. PubMed ID: 8260090
    [No Abstract]   [Full Text] [Related]  

  • 18. Cross-presentation in viral immunity and self-tolerance.
    Heath WR; Carbone FR
    Nat Rev Immunol; 2001 Nov; 1(2):126-34. PubMed ID: 11905820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in antigen processing and presentation.
    Jensen PE
    Nat Immunol; 2007 Oct; 8(10):1041-8. PubMed ID: 17878914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.